744 research outputs found

    Catatonia during deep brain stimulator implantation complicated by intracranial hemorrhage

    Full text link
    No abstract.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/77450/1/23041_ftp.pd

    Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega‐3 plasma concentrations are altered by treatment

    Full text link
    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/115916/1/bdi12337_am.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/115916/2/bdi12337.pd

    Mirtazapine Augmentation for Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: A Retropective Investigation

    Get PDF
    The aim of the present study was to retrospectively identify sexual dysfunction changes in the patients under mirtazapine-augmented serotonin reuptake inhibito (SSRI) treatment. The study comprised medical records of 20 outpatients, under mirtazapine-augmented SSRI treatment for their major depressive disorder, who had been selected among the patients that had developed sexual dysfunction to previous treatment as monotherapy, with SSRI for at least six weeks. These drugs were maintained and mirtazapine were added (15-45 mg/day). There was a significant difference in scores between baseline and week 4 or week 8 on the both Hamilton Depression Rating and Arizona Sexual Experience Scale. According to Clinical Global Impression-Improvement, 68.4% of the patients were responders. The use of low-dose mirtazapine as an add-on treatment to SSRIs appears to be an effective and well-tolerated augmenttaion for sexual dysfunction caused by SSRIs

    Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder

    Get PDF
    Selective serotonin reuptake inhibitors have proven efficacy in the treatment of panic disorder, obsessive–compulsive disorder, post-traumatic stress disorder and social anxiety disorder. Accumulating data shows that selective serotonin reuptake inhibitor treatment can also be efficacious in patients with generalized anxiety disorder. This review summarizes the findings of randomized controlled trials of selective serotonin reuptake inhibitor treatment for generalized anxiety disorder, examines the strengths and weaknesses of other therapeutic approaches and considers potential new treatments for patients with this chronic and disabling anxiety disorder

    Fluphenazine decanoate (depot) and enanthate for schizophrenia

    Get PDF
    corecore